Apalutamide will decrease the extent or result of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of apalutamide, a robust CYP3A4 inducer, with medicine that are CYP3A4 substrates can result in decrease publicity to those drugs. If jaundice develops in any female getting this sort https://zionypaox.thezenweb.com/new-step-by-step-map-for-wymzya-fe-68206345